Preliminary results show that two new Ebola drugs appear to be highly effective when it comes to treating people with the virus. Scientists studied four experimental drugs, and found that a compound developed by Regeneron Pharmaceuticals and another created by U.S. National Institutes of Health (NIH) "may be able to improve the survival of people with Ebola," Dr. Anthony Fauci of the NIH told The Associated Press. The drugs are both antibodies that block the virus, and researchers found a mortality rate of 30 percent for those who received the treatments; the mortality rate for another drug, ZMapp, was 50 percent. The earlier people received...Preliminary results show that two new Ebola drugs appear to be highly effective when it comes to treating people with the virus. Scientists studied four experimental drugs, and found that a compound developed by Regeneron Pharmaceuticals and another created by U.S. National Institutes of Health (NIH) "may be able to improve the survival of people with Ebola," Dr. Anthony Fauci of the NIH told The Associated Press. The drugs are both antibodies that block the virus, and researchers found a mortality rate of 30 percent for those who received the treatments; the mortality rate for another drug, ZMapp, was 50 percent. The earlier people received...
Share this Article
Comments
##username##
##datetime##
##comment##
##commentlikeno##Likes
##commentdislikeno##Dislikes
Please to comment